Walk in interview for pharmacists (3 posts) at MBMC
Mira Bhaindhar muncipal corporation invites eligible candidates for filling up vacant positions by walk in interview for medical services.
Soligenix Inc announced that the Chinese Patent Office intends to grant the patent entitled “Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity.” The newly issued patent claims composition of matter of dusquetide (research name: SGX94) and related analogs.
AbbVie announced that with eight weeks of treatment, 97-98 percent of genotype 1-3 (GT1-3) chronic hepatitis C virus (HCV) infected patients without cirrhosis treated with AbbVie's investigational, once-daily, ribavirin (RBV)-free, pan-genotypic regimen of ABT-493 and ABT-530 achieved sustained virologic response at 12 weeks post-treatment (SVR12).
Neovacs, a leader in active immunotherapies for the treatment of autoimmune diseases, announced that South Korea health authority approved Neovacs’s Investigational New Drug application for IFN Kinoid in phase IIb development in Lupus.